Orofar Forte Med A Citron

Lidocaine Hydrochloride Monohydrate, the active ingredient in Orofar Forte Med A Citron, is a local anesthetic presented as a topical formulation for oral mucosal use. It provides temporary numbing of the mouth and throat and is combined with antiseptic agents amylmetacresol and 2,4‑dichlorobenzyl alcohol to relieve sore‑throat discomfort.

GNH USA supplies Orofar Forte Med A Citron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orofar Forte Med A Citron, a combination of local anesthetic and antiseptic agents, is used for symptomatic relief of minor throat and oral mucosal irritation.

- Sore throat: provides temporary numbing and antimicrobial effect to ease discomfort. - Mouth ulcer: alleviates pain and reduces bacterial colonisation on ulcerated tissue. - Post‑operative oral discomfort: helps manage mild pain after dental or minor oral procedures.

Adverse reactions may occur with topical use of Orofar Forte Med A Citron.

Common Side Effects: - Mild oral irritation: transient burning or tingling sensation. - Transient numbness: temporary loss of sensation in the treated area. - Altered taste: brief metallic or bitter taste perception. - Headache: mild headache in some users. - Nausea: occasional mild nausea after use. - Localized swelling: minor swelling of the oral mucosa.

Serious or Rare Side Effects: - Allergic reaction: angioedema, urticaria or anaphylaxis requiring immediate medical attention. - Severe mucosal ulceration: unexpected deep ulcer formation. - Systemic toxicity: signs of central nervous system depression such as dizziness, seizures or cardiac arrhythmia if excessive amounts are absorbed. - Respiratory depression: rare but possible with high systemic levels. - Cardiovascular effects: hypotension or bradycardia in susceptible individuals. - Persistent numbness: prolonged loss of sensation beyond expected duration.

Safe use of Orofar Forte Med A Citron requires attention to several precautionary measures. - Age limitation: avoid use in children under the age specified by the prescribing information. - Hypersensitivity: do not use if the patient has known allergy to lidocaine, amylmetacresol or 2,4‑dichlorobenzyl alcohol. - Frequency: adhere to the recommended dosing interval and do not exceed the maximum daily applications. - Liver impairment: exercise caution in patients with severe hepatic dysfunction as lidocaine metabolism may be reduced. - Concomitant topical anesthetics: avoid simultaneous use of other oral anesthetic products to prevent cumulative toxicity. - Store at ambient temperature: keep in the original packaging, protect from moisture and excessive heat.

Orofar Forte Med A Citron may interact with other medicines; awareness of the level of interaction helps manage risk.

Major Interactions (Avoid): - Other lidocaine‑containing products: concurrent systemic or topical lidocaine can lead to cumulative toxicity. - Intravenous lidocaine therapy: simultaneous use may increase plasma lidocaine concentrations. - MAO inhibitors: may potentiate cardiovascular effects of lidocaine.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance central nervous system depression when combined with lidocaine. - CYP450 inhibitors (e.g., cimetidine, erythromycin): may slow lidocaine metabolism, raising plasma levels. - Anticoagulants: caution if oral lesions bleed, as local irritation could increase bleeding risk. - Herbal supplements affecting liver enzymes: monitor for altered lidocaine clearance.